Current Topics in Medicinal Chemistry

Editor-in-Chief

Jia Zhou
Chemical Biology Program
Department of Pharmacology and Toxicology
University of Texas Medical Branch
Galveston, TX
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 5 Issue: 5, June

Editorial [Hot Topic: Benefits, Problems and Alternatives to COX-2 Inhibition (Guest Editor: Angel Lanas)]

Volume:5   Issue: 5
Pp: 441-442
A. Lanas
DOI: 10.2174/1568026054201622
Published on: 01 March, 2012

COX-2 Selective Inhibitors in the Treatment of Arthritis: A Rheumatologist Perspective

Volume:5   Issue: 5
Pp: 443-448
M. C. Hochberg
DOI: 10.2174/1568026054201695
Published on: 01 March, 2012

Impact of COX-2 Inhibitors in Common Clinical Practice a Gastroenterologists Perspective

Volume:5   Issue: 5
Pp: 449-464
F. S. Lehmann and C. Beglinger
DOI: 10.2174/1568026054201703
Published on: 01 March, 2012

Global Safety of Coxibs and NSAIDs

Volume:5   Issue: 5
Pp: 465-473
K. Pham and R. Hirschberg
DOI: 10.2174/1568026054201640
Published on: 01 March, 2012

COX Inhibition and NSAID-Induced Gastric Damage - Roles in Various Pathogenic Events

Volume:5   Issue: 5
Pp: 475-486
K. Takeuchi, A. Tanaka, Y. Hayashi and A. Yokota
DOI: 10.2174/1568026054201668
Published on: 01 March, 2012

Dual COX-Inhibitors: The Answer is NO?

Volume:5   Issue: 5
Pp: 487-492
S. Fiorucci and E. Antonelli
DOI: 10.2174/1568026054201677
Published on: 01 March, 2012

Low Dose Aspirin, COX-Inhibition and Chemoprevention of Colorectal Cancer

Volume:5   Issue: 5
Pp: 493-503
R. Benamouzig, B. Uzzan, J. Little and S. Chaussade
DOI: 10.2174/1568026054201631
Published on: 01 March, 2012

Mechanisms of Colon Cancer Prevention with and Beyond COX-2 Inhibition

Volume:5   Issue: 5
Pp: 505-516
F. Rodriguez-Moranta and A. Castells
DOI: 10.2174/1568026054201686
Published on: 01 March, 2012

Chemoprevention of Colorectal Cancer: Ready for Routine Use?

Volume:5   Issue: 5
Pp: 517-525
N. Arber and B. Levin
DOI: 10.2174/1568026054201659
Published on: 01 March, 2012